Drug:
Reaction: VISUAL IMPAIRMENT
20260101 - 20261231
No. 101 - 200
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 101 | 26536649 |
US |
1 | |
Visual impairment, Incorrect dose administered, |
||||
INSULIN LISPRO, |
||||
| 102 | 26536826 |
EU |
77 | 2 |
Knee arthroplasty, Arrhythmia, Blister, Skin discolouration, Mouth ulceration, Visual impairment, Rash, |
||||
| 103 | 26536983 |
US |
73 | 2 |
Neoplasm malignant, Urticaria, Visual impairment, Product storage error, Extra dose administered, Expired product administered, Drug ineffective, |
||||
INSULIN GLULISINE, |
||||
| 104 | 26537391 |
US |
25 | 2 |
Cough, Visual impairment, Feeling hot, |
||||
HYDROXYZINE, ESCITALOPRAM, FERRIC DERISOMALTOSE, LAMOTRIGINE, CETIRIZINE HYDROCHLORIDE, |
||||
| 105 | 26537394 |
GB |
51 | 1 |
Angle closure glaucoma, Lens dislocation, Ocular discomfort, Corneal oedema, Visual impairment, |
||||
| 106 | 26537940 |
US |
36 | 2 |
Vision blurred, Migraine, Visual impairment, Ocular discomfort, |
||||
UPADACITINIB, GALCANEZUMAB-GNLM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, DICLOFENAC, DICLOFENAC SODIUM, CITALOPRAM, CITALOPRAM HYDROBROMIDE, RIMEGEPANT SULFATE, LAMOTRIGINE, |
||||
| 107 | 26537991 |
CA |
43 | 2 |
Type 2 diabetes mellitus, Abdominal pain, Abdominal pain upper, Adverse event, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Anxiety, Arthralgia, Arthropathy, Blister, Breast cancer stage III, Chest pain, Condition aggravated, Decreased appetite, Diarrhoea, Disability, Dizziness, Duodenal ulcer perforation, Dyspnoea, Nausea, Pruritus, Osteoarthritis, Pneumonia, Product use issue, Fatigue, Bronchitis, Grip strength decreased, Oedema, Drug hypersensitivity, Seronegative arthritis, Gait disturbance, Intentional product use issue, Insomnia, Adverse drug reaction, Therapeutic product effect incomplete, Amnesia, Therapeutic response decreased, Pyrexia, Treatment failure, Adjustment disorder with depressed mood, Liver function test increased, Muscular weakness, Dislocation of vertebra, Therapeutic product effect decreased, Upper respiratory tract infection, Hepatic enzyme increased, Foot deformity, Sciatica, Spondylitis, Mobility decreased, Oedema peripheral, Musculoskeletal stiffness, Rheumatic fever, Injury, Joint dislocation, Sinusitis, Headache, Swollen joint count increased, Delirium, Visual impairment, Weight decreased, C-reactive protein increased, Hypersensitivity, Osteoporosis, Discomfort, Tachycardia, Hypertension, Contraindicated product administered, Joint range of motion decreased, Drug tolerance decreased, Retinitis, Blood cholesterol increased, Depression, Drug-induced liver injury, Drug ineffective, Vomiting, Helicobacter infection, Hypoaesthesia, Infection, Infusion related reaction, Joint swelling, Live birth, Liver injury, Malaise, Maternal exposure during pregnancy, Memory impairment, Muscle injury, Off label use, Pain, Pemphigus, Pericarditis, Peripheral swelling, Product use in unapproved indication, Psoriasis, Psoriatic arthropathy, Rash, Rheumatoid arthritis, Abdominal discomfort, Walking aid user, Wheezing, Wound, Wound infection, Exposure during pregnancy, Fibromyalgia, General physical health deterioration, Glossodynia, Hand deformity, Prescribed overdose, Rheumatoid factor positive, Sleep disorder, Swelling, Synovitis, Systemic lupus erythematosus, Therapy non-responder, Treatment noncompliance, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CANDESARTAN, CANDESARTAN, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ERENUMAB-AOOE, ERENUMAB-AOOE, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, CALCIUM CARBONATE, CALCIUM CARBONATE, CALCIUM CARBONATE, CALCIUM CARBONATE, SARILUMAB, PREGABALIN, PREGABALIN, PREDNISONE, TRIPROLIDINE HYDROCHLORIDE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, OXYCODONE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, VITAMIN C, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, LEFLUNOMIDE, LEFLUNOMIDE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, FOLIC ACID, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, RITUXIMAB, RITUXIMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ETANERCEPT, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, APREMILAST, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, NAPROXEN, NAPROXEN SODIUM, APREPITANT, APREPITANT, APREPITANT, APREPITANT, APREPITANT, APREPITANT, APREPITANT, APREPITANT, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METHYLPREDNISOLONE SODIUM SUCCINATE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, PREGABALIN, SARILUMAB, APREMILAST, APREMILAST, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, TOFACITINIB CITRATE, TOFACITINIB CITRATE, TOFACITINIB, TOFACITINIB CITRATE, TOFACITINIB, TOFACITINIB CITRATE, TOFACITINIB, TOFACITINIB CITRATE, GOLIMUMAB, GOLIMUMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, VEDOLIZUMAB, |
||||
| 108 | 26538059 |
US |
||
Visual impairment, Headache, |
||||
DUPILUMAB, |
||||
| 109 | 26538301 |
US |
12 | 1 |
Visual impairment, |
||||
SERDEXMETHYLPHENIDATE AND DEXMETHYLPHENIDATE, |
||||
| 110 | 26538392 |
US |
85 | 1 |
Visual impairment, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 111 | 26538407 |
US |
68 | 1 |
Malignant neoplasm progression, Neuropathy peripheral, Vocal cord paralysis, Haemoptysis, General physical condition abnormal, White blood cell count increased, Decreased appetite, Blood alkaline phosphatase increased, Blood sodium decreased, Blood chloride decreased, Fatigue, Dysphonia, Cough, Arthralgia, Myalgia, Weight decreased, Haemoglobin decreased, Haematocrit decreased, Blood glucose increased, Seborrhoeic dermatitis, Pruritus, Normocytic anaemia, Hypertension, Oedema, Off label use, Drug intolerance, Oedema peripheral, Erythema, Confusional state, Dysphonia, Respiratory disorder, Gastrooesophageal reflux disease, Nausea, Vomiting, Hypoglycaemia, Visual impairment, Dyspnoea, Dyspnoea, |
||||
OLAPARIB, OLAPARIB, NICOTINE POLACRILEX, |
||||
| 112 | 26538540 |
US |
80 | 2 |
Eye pain, Weight decreased, Visual impairment, |
||||
FARICIMAB, FARICIMAB, FARICIMAB, FARICIMAB, METOPROLOL TARTRATE, METOPROLOL, GABAPENTIN, DICYCLOMINE HYDROCHLORIDE, SIMVASTATIN, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, CLONAZEPAM, CLONAZEPAM, BUPROPION HYDROCHLORIDE, VITAMIN E, VITAMIN C, BIOTIN, ACETAMINOPHEN, ACETAMINOPHEN, ERGOCALCIFEROL, FOLIC ACID, FERROUS SULFATE, MAGNESIUM OXIDE, FISH OIL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 113 | 26538622 |
US |
84 | |
Visual impairment, Vitamin A decreased, |
||||
VUTRISIRAN, |
||||
| 114 | 26538766 |
US |
||
Visual impairment, Headache, |
||||
VANZACAFTOR, TEZACAFTOR, AND DEUTIVACAFTOR, |
||||
| 115 | 26538893 |
US |
||
Rash, Visual impairment, |
||||
ENCORAFENIB, ENCORAFENIB, BINIMETINIB, BINIMETINIB, |
||||
| 116 | 26538945 |
AU |
||
Mental impairment, Retinopathy, Neuropathy peripheral, Burnout syndrome, Disturbance in attention, Hypoaesthesia, Paraesthesia, Visual impairment, |
||||
INSULIN ASPART INJECTION, INSULIN ASPART, INSULIN ASPART, INSULIN GLARGINE, |
||||
| 117 | 26539386 |
US |
57 | 2 |
Product dose omission issue, Accidental exposure to product, Psoriasis, Visual impairment, |
||||
GUSELKUMAB, GUSELKUMAB, |
||||
| 118 | 26539579 |
US |
76 | 2 |
Visual impairment, Condition aggravated, Eye irritation, Eye pain, |
||||
ACOLTREMON, EZETIMIBE, GABAPENTIN, PANTOPRAZOLE SODIUM, ROSUVASTATIN, VALSARTAN, VALSARTAN ORAL, CETIRIZINE HYDROCHLORIDE, |
||||
| 119 | 26539647 |
US |
49 | 1 |
Periorbital swelling, Ocular hyperaemia, Visual impairment, Eye irritation, Eye pain, |
||||
ACOLTREMON, FUTIBATINIB, LYTGOBI, PANTOPRAZOLE, |
||||
| 120 | 26539675 |
US |
2 | |
Pain, Visual impairment, Hypertension, |
||||
RAVULIZUMAB, |
||||
| 121 | 26539789 |
US |
77 | 2 |
Visual impairment, Condition aggravated, |
||||
ACOLTREMON, ROSUVASTATIN, ESOMEPRAZOLE MAGNESIUM, PREDNISONE, LEVOTHYROXINE SODIUM, |
||||
| 122 | 26539804 |
US |
72 | 2 |
Visual impairment, Eye irritation, |
||||
ACOLTREMON, BIOTIN, MAGNESIUM, ERGOCALCIFEROL, |
||||
| 123 | 26539952 |
US |
2 | |
Condition aggravated, Visual impairment, Drug ineffective, Product storage error, Eye pain, Eye irritation, |
||||
ACOLTREMON, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, MONTELUKAST, PANTOPRAZOLE, |
||||
| 124 | 26539957 |
US |
71 | 1 |
Eye disorder, Visual impairment, Drug hypersensitivity, |
||||
ACOLTREMON, ALENDRONATE SODIUM, ALENDRONATE SODIUM TABLET, AMLODIPINE, CARVEDILOL, IRBESARTAN, |
||||
| 125 | 26540081 |
US |
85 | 2 |
Visual impairment, Drug ineffective, Eye irritation, |
||||
ACOLTREMON, AMLODIPINE, FAMOTIDINE, PREGABALIN, ERGOCALCIFEROL, |
||||
| 126 | 26540089 |
US |
73 | 2 |
Visual impairment, Eye irritation, |
||||
ACOLTREMON, |
||||
| 127 | 26540293 |
US |
81 | 2 |
Visual impairment, Eye pain, |
||||
ACOLTREMON, ACOLTREMON, AMLODIPINE BESYLATE, LORATADINE, LORATADINE TABLET, HYDROCHLOROTHIAZIDE, LOSARTAN, MELOXICAM, |
||||
| 128 | 26540339 |
US |
74 | 2 |
Eye pruritus, Ocular hyperaemia, Visual impairment, Eye irritation, |
||||
ACOLTREMON, ACARBOSE, ALPRAZOLAM, BACLOFEN, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, MELATONIN, MEMANTINE, MEMANTINE HYDROCHLORIDE, |
||||
| 129 | 26540455 |
US |
60 | 2 |
Visual impairment, Eye irritation, |
||||
ACOLTREMON, |
||||
| 130 | 26540637 |
US |
64 | 1 |
Ocular stroke, Visual impairment, Cataract, |
||||
ADALIMUMAB, TIRZEPATIDE, |
||||
| 131 | 26540755 |
US |
80 | 2 |
Visual impairment, |
||||
ACOLTREMON, LATANOPROST, |
||||
| 132 | 26540768 |
US |
74 | 1 |
Ocular hyperaemia, Eye pruritus, Visual impairment, Eye irritation, |
||||
ACOLTREMON, |
||||
| 133 | 26540781 |
US |
2 | |
Mydriasis, Visual impairment, Eye irritation, |
||||
ACOLTREMON, AMLODIPINE, |
||||
| 134 | 26540784 |
US |
77 | 2 |
Eye pruritus, Visual impairment, Condition aggravated, |
||||
ACOLTREMON, TENOFOVIR ALAFENAMIDE, |
||||
| 135 | 26540845 |
US |
71 | 1 |
Eye irritation, Visual impairment, |
||||
ACOLTREMON, |
||||
| 136 | 26541339 |
US |
51 | 2 |
Ischaemia, Intraocular pressure increased, Altered visual depth perception, Visual impairment, Ocular hyperaemia, Vision blurred, Vision blurred, |
||||
TADALAFIL, TIRZEPATIDE, |
||||
| 137 | 26541358 |
US |
77 | 2 |
Visual impairment, Dry eye, Eye irritation, Product storage error, |
||||
ACOLTREMON, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, |
||||
| 138 | 26541388 |
US |
57 | 2 |
Visual impairment, Condition aggravated, Eye irritation, |
||||
ACOLTREMON, TRIAMTERENE CAPSULES, TRIAMTERENE, |
||||
| 139 | 26541432 |
US |
64 | 1 |
Eyelid irritation, Visual impairment, |
||||
ACOLTREMON, ALBUTEROL SULFATE, ALBUTEROL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, IRBESARTAN, CARVEDILOL, TADALAFIL, CYANOCOBALAMIN, GLIPIZIDE, METRONIDAZOLE, METRONIDAZOLE TOPICAL, SEMAGLUTIDE, ORAL SEMAGLUTIDE, FAMOTIDINE, PANTOPRAZOLE SODIUM, TIOTROPIUM BROMIDE, ICOSAPENT ETHYL, ERGOCALCIFEROL, DICLOFENAC SODIUM, DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE, TESTOSTERONE ENANTHATE, |
||||
| 140 | 26541452 |
US |
76 | 2 |
Visual impairment, Eye irritation, |
||||
DEXTRAN, HYPROMELLOSE, ACOLTREMON, CHLORTHALIDONE, CYCLOSPORINE, DENOSUMAB, URSODIOL, URSOSIOL, ERGOCALCIFEROL, LOTILANER OPHTHALMIC SOLUTION, TIZANIDINE HYDROCHLORIDE, |
||||
| 141 | 26541482 |
US |
85 | 2 |
Vision blurred, Visual impairment, |
||||
ACOLTREMON, ATORVASTATIN CALCIUM, |
||||
| 142 | 26541507 |
US |
63 | 2 |
Visual impairment, Eye pain, |
||||
ACOLTREMON, |
||||
| 143 | 26541535 |
US |
44 | 2 |
Eye irritation, Visual impairment, |
||||
ACOLTREMON, |
||||
| 144 | 26541778 |
US |
71 | 1 |
Visual impairment, Eye irritation, Lacrimation increased, |
||||
ACOLTREMON, ROSUVASTATIN, FENOFIBRATE, PREGABALIN, AMLODIPINE BESYLATE, |
||||
| 145 | 26541854 |
US |
74 | 2 |
Visual impairment, Injection site bruising, |
||||
TIRZEPATIDE, |
||||
| 146 | 26543742 |
71 | 2 | |
Eyelid margin crusting, Visual impairment, |
||||
LEBRIKIZUMAB-LBKZ, |
||||
| 147 | 26531432 |
US |
||
Product storage error, Visual impairment, |
||||
| 148 | 26531485 |
GB |
16 | 2 |
Malaise, Visual impairment, Headache, |
||||
METHYLPHENIDATE, METHYLPHENIDATE HYDROCHLORIDE, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ATOMOXETINE, PROMETHAZINE HYDROCHLORIDE, |
||||
| 149 | 26532169 |
US |
2 | |
Visual impairment, Device malfunction, Wrong technique in device usage process, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 150 | 26532613 |
US |
1 | |
Neuropathy peripheral, Fatigue, Headache, Pain in jaw, Rhinorrhoea, Visual impairment, |
||||
EVOLOCUMAB, |
||||
| 151 | 26533703 |
77 | ||
Ocular discomfort, Visual impairment, Headache, Off label use, |
||||
RUXOLITINIB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ALLOPURINOL, ASCORBIC ACID, SULFAMETHOXAZOLE AND TRIMETHOPRIM, PANCRELIPASE, DICYCLOMINE HYDROCHLORIDE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, INSULIN ASPART, LISINOPRIL, MAGNESIUM OXIDE, MIRABEGRON, FISH OIL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 152 | 26533717 |
US |
2 | |
Visual impairment, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 153 | 26533796 |
ZA |
55 | 2 |
Optical coherence tomography abnormal, Off label use, Visual impairment, Retinal thickening, |
||||
FARICIMAB, FARICIMAB, |
||||
| 154 | 26533825 |
US |
72 | 2 |
Wound, Fall, Rheumatoid arthritis, Injection site mass, Visual impairment, |
||||
EVOLOCUMAB, EVOLOCUMAB, ETANERCEPT, PREDNISONE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 155 | 26534039 |
US |
55 | 2 |
Visual impairment, Product storage error, |
||||
INSULIN GLARGINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 156 | 26534730 |
US |
60 | 1 |
Visual impairment, Product storage error, |
||||
INSULIN GLARGINE, |
||||
| 157 | 26534799 |
EU |
74 | 2 |
Speech disorder, White matter lesion, Muscular weakness, Cerebral atrophy, Photophobia, Gait disturbance, Paraesthesia, Visual impairment, Migraine with aura, Hemiplegic migraine, Headache, Nausea, Migraine, |
||||
LETROZOLE, LETROZOLE TABLETS, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 158 | 26534970 |
IN |
18 | 1 |
Visual impairment, |
||||
DEXAMETHASONE, DEXAMETHASONE, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, |
||||
| 159 | 26535339 |
US |
77 | 2 |
Blood glucose increased, Illness, Hypoacusis, Wrong technique in product usage process, Visual impairment, |
||||
INSULIN LISPRO, |
||||
| 160 | 26535530 |
US |
68 | 1 |
Memory impairment, Visual impairment, |
||||
DIROXIMEL FUMARATE, |
||||
| 161 | 26538438 |
55 | 2 | |
Visual impairment, Eye swelling, Eye pruritus, Eye pain, |
||||
DUPILUMAB, |
||||
| 162 | 26527100 |
US |
66 | 2 |
Seizure, Abdominal pain, Dry throat, Nasal congestion, Dizziness, Diarrhoea, Dry mouth, Oropharyngeal pain, Gait disturbance, Visual impairment, Headache, Pain, Drug ineffective, |
||||
LAMOTRIGINE, LAMOTRIGINE, |
||||
| 163 | 26527245 |
US |
1 | |
Hallucination, Balance disorder, Visual impairment, Walking aid user, Fall, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 164 | 26527421 |
US |
58 | 2 |
Uterine cancer, Surgery, Eating disorder, Brain fog, Overweight, Rheumatoid arthritis, Unevaluable event, Rash, Visual impairment, Dermatitis, |
||||
UPADACITINIB, UPADACITINIB, UPADACITINIB, UPADACITINIB, |
||||
| 165 | 26527522 |
EU |
65 | 1 |
Visual impairment, |
||||
PREGABALIN, TACROLIMUS, |
||||
| 166 | 26528650 |
EU |
52 | 1 |
Pneumothorax, Visual impairment, Restlessness, Gastrointestinal pain, Nocturia, Balance disorder, Loss of personal independence in daily activities, Aphasia, Parkinsonian gait, Restlessness, Pollakiuria, Parkinsonian gait, Dyschezia, Memory impairment, Device use issue, Gastrointestinal stoma complication, Dystonia, Muscle spasms, Weight decreased, Abnormal dreams, Insomnia, Stoma site discharge, Stoma site discharge, Dyskinesia, Therapeutic product effect incomplete, Dizziness, Orthostatic hypotension, Dizziness, Insomnia, Abnormal dreams, Stoma site discharge, Dyskinesia, Stoma site inflammation, Hyperkinesia, Middle insomnia, Bradykinesia, Unevaluable event, Hallucination, Medical device site scab, Hallucination, visual, Stoma site erythema, Stoma site irritation, Fall, Musculoskeletal chest pain, Unevaluable event, Peroneal nerve palsy, Muscle rigidity, Psychomotor hyperactivity, Head discomfort, Device breakage, Gait disturbance, Stoma site discharge, Somnolence, Poor quality sleep, Hunger, Brain fog, Device issue, Micturition urgency, Device power source issue, Device issue, Device connection issue, Fall, Pain, Mobility decreased, |
||||
| 167 | 26529093 |
US |
70 | 2 |
Deafness, Bile duct stone, Impaired gastric emptying, Visual impairment, Memory impairment, |
||||
SEMAGLUTIDE, ORAL SEMAGLUTIDE, SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 168 | 26529801 |
US |
68 | 2 |
Hepatic cancer, Visual impairment, Blood glucose increased, |
||||
SEMAGLUTIDE, ORAL SEMAGLUTIDE, DAPAGLIFLOZIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 169 | 26529900 |
US |
75 | 2 |
Cerebrovascular accident, Visual impairment, Urinary incontinence, |
||||
DAPAGLIFLOZIN, |
||||
| 170 | 26529913 |
US |
77 | 1 |
Blood pressure abnormal, Fall, Injury, Craniofacial fracture, Fall, Dizziness, Visual impairment, Incorrect dose administered, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 171 | 26530055 |
US |
80 | 1 |
Thrombosis, Vascular occlusion, Visual impairment, Pulmonary thrombosis, |
||||
ALLOPURINOL, MAGNESIUM HYDROXIDE, POLYETHYLENE GLYCOL 3350, EMPAGLIFLOZIN, FUROSEMIDE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, MIDODRINE HYDROCHLORIDE, ROSUVASTATIN, VALSARTAN, VALSARTAN ORAL, ERGOCALCIFEROL, |
||||
| 172 | 26530191 |
US |
71 | 1 |
Visual impairment, Incorrect dose administered, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 173 | 26530394 |
US |
71 | 2 |
Visual impairment, |
||||
DULAGLUTIDE, |
||||
| 174 | 26530701 |
US |
73 | 2 |
Visual impairment, |
||||
INTERFERON BETA-1A, |
||||
| 175 | 26531090 |
US |
81 | |
Illness, Visual impairment, |
||||
FARICIMAB, FARICIMAB, FARICIMAB, FARICIMAB, |
||||
| 176 | 26522873 |
US |
65 | 1 |
Visual impairment, Device issue, Incorrect dose administered by device, Device malfunction, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 177 | 26523183 |
US |
2 | |
Visual impairment, |
||||
RIBOCICLIB, |
||||
| 178 | 26523446 |
US |
1 | |
Swelling of eyelid, Visual impairment, Burning sensation, Pruritus, |
||||
LIFITEGRAST, LIFITEGRAST, PERFLUOROHEXYLOCTANE, |
||||
| 179 | 26523490 |
US |
63 | 2 |
Visual impairment, |
||||
INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, |
||||
| 180 | 26523496 |
CA |
1 | |
Visual impairment, Retinal artery occlusion, Cataract, |
||||
BENRALIZUMAB, BENRALIZUMAB, ALBUTEROL SULFATE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ROSUVASTATIN, AMLODIPINE, ALBUTEROL SULFATE, ALBUTEROL, IPRATROPIUM BROMIDE, |
||||
| 181 | 26523533 |
US |
1 | |
Visual impairment, |
||||
PREDNISOLONE ACETATE, |
||||
| 182 | 26523656 |
US |
76 | 2 |
Glaucoma, Visual impairment, Thyroid disorder, Weight increased, Inflammation, Pruritus, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 183 | 26523657 |
US |
69 | 2 |
Visual impairment, |
||||
DUPILUMAB, |
||||
| 184 | 26523854 |
US |
1 | |
Visual impairment, |
||||
BELANTAMAB MAFODOTIN, |
||||
| 185 | 26524375 |
EU |
86 | 2 |
Neutropenia, Fatigue, Dizziness, Back pain, Platelet count decreased, Asthenia, Cataract, Bacterial diarrhoea, Corneal epithelial microcysts, Visual impairment, Diarrhoea infectious, |
||||
POMALIDOMIDE, BELANTAMAB MAFODOTIN, |
||||
| 186 | 26524974 |
EU |
1 | |
Cardiac disorder, Visual impairment, |
||||
TAFAMIDIS MEGLUMINE, |
||||
| 187 | 26525049 |
US |
2 | |
Headache, Off label use, Circumstance or information capable of leading to medication error, Visual impairment, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 188 | 26525071 |
US |
63 | 2 |
Visual impairment, Urine protein/creatinine ratio increased, Diarrhoea, Weight decreased, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, VOCLOSPORIN, |
||||
| 189 | 26525518 |
ZA |
75 | 1 |
Optical coherence tomography abnormal, Retinal thickening, Visual impairment, |
||||
FARICIMAB, FARICIMAB, |
||||
| 190 | 26525562 |
EU |
2 | |
Visual impairment, |
||||
METHYLPHENIDATE HYDROCHLORIDE, |
||||
| 191 | 26525794 |
CN |
84 | 1 |
Macular degeneration, Visual impairment, Vision blurred, Hypertension, Incorrect dose administered, Blood glucose increased, Insulin resistance, |
||||
INSULIN HUMAN, |
||||
| 192 | 26526065 |
US |
||
Visual impairment, |
||||
TIRZEPATIDE, |
||||
| 193 | 26521983 |
US |
69 | 2 |
Visual impairment, Product dispensing error, |
||||
INSULIN GLARGINE, |
||||
| 194 | 26522067 |
US |
72 | |
Visual impairment, |
||||
INSULIN GLARGINE, |
||||
| 195 | 26522128 |
EU |
62 | 2 |
Choking, Breast necrosis, Faeces soft, Defaecation urgency, Constipation, Abdominal pain lower, Gastrointestinal sounds abnormal, Food aversion, Malaise, Visual impairment, Arthralgia, Bone pain, Decreased activity, Pain of skin, Cough, Frequent bowel movements, Decreased appetite, Diarrhoea, Fatigue, Asthenia, Dry skin, |
||||
ANASTROZOLE, ANASTROZOLE TABLETS, ABEMACICLIB, ABEMACICLIB, VALSARTAN, VALSARTAN ORAL, |
||||
| 196 | 26521258 |
GB |
2 | |
Visual impairment, |
||||
CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, |
||||
| 197 | 26521424 |
US |
64 | 2 |
Visual impairment, Cataract, Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 198 | 26521485 |
GB |
2 | |
Visual impairment, Productive cough, Dizziness, Dyspnoea, Cough, |
||||
MANNITOL, MANNITOL, |
||||
| 199 | 26521540 |
ZA |
1 | |
Retinal thickening, Visual impairment, |
||||
FARICIMAB, |
||||
| 200 | 26521644 |
US |
2 | |
Visual impairment, |
||||
DUPILUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28